Private placement last December Vancouver, British Columbia--(Newsfile Corp. - November 22, 2017) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces a fully subscribed non-brokered private placement (the "Financing") of up to 4,377,776 units (each, a "Unit") at a price of $0.75 per Unit to raise gross proceeds of $3,283,332. Each Unit will consist of one common share of the Company and one warrant, with each warrant entitling the holder thereof to purchase one common share of the Company at an exercise price of $0.90 per share for a period of 6 months from the closing of the Financing (the "Closing") and thereafter at an exercise price of $1.00 per share until the expiry of the period ending 12 months from the Closing. The Closing is expected to occur on or about December 8, 2017. The common shares and warrants comprising the Units will be subject to a hold period of four months and one day in Canada.
https://www.preveceutical.com/_resources/news/nr_2017-11-22.pdf
https://www.newsfilecorp.com/release/30687/PreveCeutical-Medical-Inc.-Announces-3.28-Million-Fully-Subscribed-Private-Placement